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ABSTRACT 
 Today MRI imagining techniques are capable of discerning between abnormal and normal complex 
tissues by providing contrasting images of these tissues.  One drawback of using MRI imagining is its low 
sensitivity.   However, this sensitivity can be greatly enhanced by introducing contrasting agents who can 
provide a new pathway for water molecules to significantly relax faster and hence generate the desired 
“contrast” between healthy and unhealthy tissues.   We report the first ever recorded fluorescence emission 
spectrum of Gd3N@C80(OH)20; where -(OH)20 is the average number of hydroxyl groups.  Our emission data 
indicates that the H2O- Gd3N@C80(OH)20 interactions lead to fluorescence quenching via a static quenching 
mechanism.  The binding constant, Kb, on the other hand, was found to be of the same magnitude as 
interactions between human serum albumin and small organic acid but quite different, several orders of 
magnitude smaller, than protein nanoparticle complexes.  Interestingly, the binding number, n, was found to 
be approximately 0.5, which in cases like this, is rounded to a whole number of one.  The data also indicated 
an extremely fast rate constant on the order of 10
12
 L mol
-1
 s
-1
 which is outside of the diffusion-control regime.  
These results are presented within this report. 
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INTRODUCTION 
 Modern imagining techniques, such as MRI, are able to discriminate between normal and abnormal 
tissues by generating contrasting images of these organs and/or tissues.  One drawback of employing MRI 
imagining is its relatively low sensitivity.   However, the sensitivity can be greatly enhanced by introducing 
paramagnetic species (i.e. contrasting agents) which can provide a new pathway for water molecules to relax 
significantly faster and hence generate the desired “contrast” between various tissues.  Gd
3+
 ions are idealas 
contrasting agents since their unpaired electrons and high magnetic moment provide water protons a new 
pathway for enhanced relaxation or enhanced relaxivity. 
1-3
A number of gadolinium complexes have been 
employed in magnetic resonance imagingsince their large number of unpaired electrons reduces the spin 
lattice relaxation time of H2O molecules surrounding tissues. 
4-20
Gadolinium complexes are ideal contrasting 
agents and their water solubility is frequently generated by functionalizing these complexes with groups 
ranging from  –(OH)n, -(COOH)n, and poly(ethylene glycol)n with n =8 – 114, have been reported.
11-15
Due to 
the almost spherical shape of Gd3N@C80(OH)20, one of the objectives of this study was to determine the 
average number of water molecules interacting with this complexes to determine if Gd3N@C80(OH)20-H2O 
possess the physical dimensions to cross the blood-brain-barrier allowing for imaging of brain tissues.This 
research project has the potential of introducing a non-radioactive contrasting agent with the ability to 
penetrate the blood-brain-barrier.  This compound will allow patients to receive a contrasting agent via an 
easily accessible vein which will permit the contrasting agent to differentiate between healthy brain tissue and 
potentially dangerous brain tumors. 
EXPERIMENTAL SECTION 
 Gd3N@C80(OH)20 was purchased from Luna Innovations and used as received.  The number of –OH 
hydroxyl groups very in these gadolinium complexes with an average number being twenty.  A solution of the 
probe molecule was prepared using 10 L of Gd3N@C80(OH)20 in 0.75 mL of D2O.  A fluorescence spectrum 
of this solution was taken with an excitation line at 350 nm.  A single distinctive peak was observed in the 
region of ~ 690-710 nm range.  The emission titration was initiated by systematically adding 10 L of water 
beginning with 10 L, 30 L, 60 L, 80 L and 100 L.   All fluorescence spectra were taken of these 
solutions, scanning in the 650-750 nm range, at room temperature and in a quartz cell (0.5 cm path length).  
The steady-state emission spectra was performed on a PTI QM-4CW fluorimeter system equipped with a 
xenon lamp, double monochromator  for excitation, and a photon counting R928 PMT detector.   Since 
approximately 60% of the human body is composed of H2O, it is imperative that the number of water 
molecules binding to Gd3N@C80(OH)20 be determine since the number of water molecules bound to the 
Gd3N@C80(OH)20 will regulate  the size if this complex and will determine if the macromolecule can penetrate 
the blood-brain-barrier. 
RESULTS AND DISCUSSION 
 Various types of molecular interactions including collisions, molecular rearrangements, excited state 
reactions, ground-state complex formation, and energy transfer can lead to fluorescence quenching.
21
The rate 
constant, binding constant and binding number can be determined in a straight forward manner  by fitting the 
fluorescence decay as a function of the H2O concentration; [H2O].  Figure 1 illustrates the decreasing 
fluorescence intensity indicative of a static quenching mechanism.  The main reason for the limited number of 
contrasting agents is that these contrasting agents must be able to pass the blood-brain barrier (BBB) which 
places a limit on the molecular size to a range of about 400 – 500 Da or a molecular surface cross section 
(MSCS) limit of less than 80 Å
2
.  While the molecular weight of the Gd3N@C80(OH)20 is approximately 1445 
Da, its spherical shape, gives a MSCS of 63 - 69 Å
2
, allowing this contrasting agent to penetrate the BBB. 
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Figure 1:Gd3N@C80(OH)20 with varying amounts of H2O 
The downward trend in the fluorescence intensity is best characterized by using the well-known Stern-Volmer 
equation:
21
    
 [Q]k1
F
F
0q
o   (1) 
whereFo and F are the fluorescence intensities in the absence and presence of the quencher, respectively.  
The product kqo is commonly known as the Stern-Volmer constant (KSV) with kq being the quenching rate 
constant, o is the average lifetime of the molecule in the absence of the quencher,  and [Q] is the 
concentration of the quencher (i.e. H2O).  Since o is approximately 10
-8
 sin our probe molecule,
22
 a value for 
the Gd3N@C80(OH)20 – H2Oquenching rate constant was obtained from a fit of Fo/F versus [H2O] as shown in 
Figure 2.  
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Figure 2:  Determination of the quenching rate constant, kq. 
A kq value of 9.33 x 10
12
 Lmol
-1
 s
-1
suggests the rate constant is outside the diffusion-controlled regime.For this 
type of quenching, the binding constant (Kb) and the number of binding sites (n) can be obtained by using 
equation 2:
21
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
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 (2) 
Figure 3 illustrates the fit of log(Fo-F/F) versus log[Q] with the slope being equal to binding site and the 
intercept being equated to log Kb.  The calculated fitting coefficient of 0.996 indicates that the interaction 
between Gd3N@C80(OH)20 and H2O agrees exceptionally well with the binding model as described by 
equation (2). 
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Figure 3: Determination of binding sites and Kb. 
 Interestingly, n is approximately equal to 0.5 suggesting the rate constant is very fast generating an 
average binding site of less than one.   Binding site values between 0.5 and 0.7 are commonly rounded to 
1.0.
23
  However, caution must be exercised since interactions between water and Gd3N@C80(OH)20are 
ensemble averages.  The binding constant was found to be 1.96 x 10
2
 L mol
-1
, several orders of magnitude 
smaller than protein-nanoparticle complexes but in the same order of magnitude as interactions between 
human serum albumin (HAS) and small organic acids.
24,25
  The binding constant suggests the interaction is 
not particularly long-lived which gives rise to the fractional value for the binding site.  The hydroxyl groups on 
Gd3N@C80(OH)20 can interact, via hydrogen-bonding, with the water molecules generating an effective bridge 
which enhances electron transfer via the commonly known phenomenon of proton coupled electron transfer.
26
 
CONCLUSIONS 
In summary, the first ever recorded fluorescence spectrum of Gd3N@C80(OH)20 is reported.  Our data 
indicated the H2O- Gd3N@C80(OH)20 interactions led to fluorescence quenching via a static quenching 
mechanism.  The binding constant, Kb, was found to be of the same magnitude as interactions between 
human serum albumin and small organic acid but quite different, several orders of magnitude smaller, than 
protein nanoparticle complexes.  Surprisingly, the binding site number, n, was found to round to 0.5, which in 
cases like this, is rounded to a whole number of one.  The data indicated an extremely fast rate constant on 
the order of 10
12
 L mol
-1
 s
-1
 which is outside of the diffusion-control regime.  Since Gd3N@C80(OH)20, is 
practically a spherical molecule, the fact that the binding number “n” is one, indicates that the 
Gd3N@C80(OH)20-H2O binding complexwill possess the correct physical dimensions to cross the blood-brain-
barrier allowing for imaging of brain tissues allowing for patients to receive a contrasting agent via an easily 
accessible vein which will permit the contrasting agent to differentiate between healthy brain tissue and 
potentially dangerous brain tumors. 
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